Suppr超能文献

[佐剂对抗转铁蛋白结合蛋白抗体阻断脑膜炎奈瑟菌转铁蛋白结合、铁摄取及生长能力的影响]

[Influence of adjuvants on the ability of anti-Tbp antibodies to block transferrin binding, iron uptake and growth of Neisseria meningitis].

作者信息

Ferreirós Carlos, Ferreiro Nuria, Criado M T

机构信息

Departamento de Microbiología, Facultad de Farmacia, Universidad de Santiago de Compostela, La Coruña, España.

出版信息

Enferm Infecc Microbiol Clin. 2002 Aug-Sep;20(7):316-20. doi: 10.1016/s0213-005x(02)72807-3.

Abstract

OBJECTIVE

To evaluate the effect of five adjuvants on the ability of specific anti-TbpA/B to block iron uptake in Neisseria meningitidis.

MATERIALS AND METHODS

Transferrin binding complexes (TbpA/B) purified from a TbpB isotype II Neisseria meningitidis strain were used to obtain sera with five different adjuvant formulations in mice in order to test the effect of the adjuvant on the ability of specific anti-TbpA/B antibodies to block transferrin binding, iron uptake and growth by meningococci.

RESULTS

Levels of anti-TbpA/B antibodies were relatively low (1:125 in most cases), the highest being obtained with the RAS adjuvant (1:3125). Despite the relatively low responses, all sera were able to significantly inhibit transferrin binding, iron uptake and growth in the homologous strain. Nevertheless, the effect on a strain with a TbpB isotype different from that of the immunizing strain was almost nil, a result in keeping with the described division of the meningococci into at least two TbpB groups (isotypes I and II).

CONCLUSIONS

In contrast to previous results for another important meningococcal protein, FbpA, the use of various adjuvants in the immunization of mice with TbpA/B complexes did not produce differences in the immune responses elicited, except in relation to antibody titers.

摘要

目的

评估五种佐剂对特异性抗TbpA/B阻断脑膜炎奈瑟菌摄取铁能力的影响。

材料与方法

从一株II型TbpB的脑膜炎奈瑟菌菌株中纯化转铁蛋白结合复合物(TbpA/B),用于在小鼠中获得含五种不同佐剂配方的血清,以测试佐剂对特异性抗TbpA/B抗体阻断转铁蛋白结合、铁摄取及脑膜炎球菌生长能力的影响。

结果

抗TbpA/B抗体水平相对较低(多数情况下为1:125),使用RAS佐剂时获得的抗体水平最高(1:3125)。尽管反应相对较低,但所有血清均能显著抑制同源菌株的转铁蛋白结合、铁摄取及生长。然而,对TbpB型与免疫菌株不同的菌株几乎没有影响,这一结果与将脑膜炎球菌至少分为两个TbpB组(I型和II型)的描述相符。

结论

与之前针对另一种重要的脑膜炎球菌蛋白FbpA的结果相反,用TbpA/B复合物免疫小鼠时使用各种佐剂,除抗体滴度外,所引发的免疫反应没有差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验